Bharat Biotech announced the launch of India's first indigenously developed cell culture H1N1 swine flu vaccine under the brand name 'HNVAC™'. HNVAC™ is the only developing world flu vaccine to be manufactured in cell culture, a highly sterile and controlled manufacturing process, instead of eggs. HNVAC™ was tested extensively in one of the largest Phase I, II and III clinical trials for flu vaccines in India and has proved that it is safe and well tolerated. Making the announcement Bharat Biotech's Chairman and Managing Director, Dr... 
More...
More...